Journals / Türkiye Parazitoloji Dergisi / 2019 / Cilt: 43 - Sayı: 4

Visceral Leishmaniasis in A Patient Presenting with Fever of Unknown Origin: A Case Report From a Low-endemic Region of Turkey

Türkiye’nin Düşük Endemik Bölgesinden Nedeni Bilinmeyen Ateşle Başvuran Bir Visseral Leyişmaniyaz Olgusu

Pages
210–212
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

At 6 months of follow-up, no sign of recurrence was observed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Leishmaniasis is a neglected disease that is prevalent in tropical and subtropical regions of the world.
📊
Key Findings & Data:The case presented herein isa 39 year-old bed-ridden female who presented with fever of unknown origin, tachypnea and pancytopenia.
💡
Conclusion & Impact:At 6 months of follow-up, no sign of recurrence was observed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Leishmaniasis is a neglected disease that is prevalent in tropical and subtropical regions of the world. Even though cutaneousleishmaniasis is the most common form, visceral leishmaniasis is associated with high mortality. The case presented herein isa 39 year-old bed-ridden female who presented with fever of unknown origin, tachypnea and pancytopenia. She was initiallymisdiagnosed as having autoimmune pancytopenia elsewhere and treated with corticosteroids and intravenous immunoglobulin.She had also received wide-spectrum antibiotics for febrile neutropenia. We performed a leishmania rK39 dipstick test whichturned out to be positive along with visualisation of amastigote forms of leishmania on bone marrow biopsy. Thus, we madea diagnosis of visceral leishmaniasis and treated her with liposomal amphotericin B. Her clinical course was complicated byrespiratory failure necessitating invasive mechanical ventilation. She responded well to treatment and was later extubated, shortly before being discharged. At 6 months of follow-up, no sign of recurrence was observed.

Özet

Leyişmaniyaz, tropik ve subtropik bölgelerde sık görülen ihmal edilmiş bir hastalıktır. Kutanöz leyişmaniyaz en sık görülen formu olsa da visseral leyişmaniyaz yüksek mortalite ile ilişkili olanıdır. Bu olgu sunumunda nedeni bilinmeyen ateş, takipne ve pansitopeni ile prezente olan 39 yaşında yatağa bağımlı bir kadın hasta rapor edilmektedir. Başka bir merkezde otoimmün pansitopeni tanısı ile kortikosteroid ve intravenöz immünoglobulin tedavileri, febril nötropeni için geniş spektrumlu antibiyotik tedavisi almıştır. Hastanın merkezimizde yapılan leyişmaniyaz rK39 dipstik testi pozitif sonuçlandı ve kemik iliği biyopsisinde amastigot formları görüldü. Hastaya visseral leyişmaniyaz tanısı konularak lipozomal amfoterisin B tedavisi başlandı. Klinik seyri invaziv mekanik ventilasyonu gerektirecek solunum yetmezliği ile komplike oldu. Tedaviye iyi yanıt veren hasta ekstübe edildi ve daha sonra taburcu edildi. Taburculuktan 6 ay sonraki kontrolünde relaps bulgusu saptanmadı.

🔖

Cite This Article

Üner, A., Akman, O., Özışık, L., Jaiteh, M. B., Tortop, S., Çapın, B. B. Ö., İnkaya, A. Ç., Hasanlı, N., Başaran, N. Ç., Hüseyinova, S. (2022). Visceral Leishmaniasis in A Patient Presenting with Fever of Unknown Origin: A Case Report From a Low-endemic Region of Turkey. Türkiye Parazitoloji Dergisi, Cilt: 43 - Sayı: 4, 210–212. https://ajindex.com/articles/630027

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. World Health Organization. Leishmaniasis. Available from: http:// www.who.int/leishmaniasis/disease/clinical_forms_leishmaniases/en/ index2.html 2. Centers for Disease Control and Prevention (CDC). Epidemiology and Risk factors of Leishmaniasis. Available from: https://www.cdc.gov/ parasites/leishmaniasis/epi.html 3. World Health Organization. Report of a meeting of the WHO Expert Committee on the control of leishmaniases. WHO Technical Report Series: 2010 Mar. Report no.: 949. 4. World Health Organization. Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Weekly Epidemiological Record 2016;91:285-96. 5. Gürel MS, Yeşilova Y, Ölgen MK, Özbel Y. Cutaneous leishmaniasis in Turkey. Turkiye Parazitol Derg 2012;36:121-9. 6. Koltas IS, Eroglu F, Alabaz D, Uzun D. The emergence of Leishmania major and Leishmania donovani in southern Turkey. Trans R Soc Trop Med Hyg 2014;108:154-8. 7. Pullukçu H, Turgay N, Işıkgöz Taşbakan M, Akyol D, Sipahi OR, Yamazhan T, et al. Fever of Unknown Origin and Visceral Leishmaniasis: a series of 20 Adult Patients. FLORA 2018;23:92-4. 8. Kawakami A, Fukunaga T, Usui M, Asaoka H, Noda M, Nakajima T,et al. Visceral Leishmaniasis misdiagnosed as malignant lymphoma. Intern Med 1996;35:502-6. 9. Ozensoy Toz S, Sakru N, Ertabaklar H, Demir S, Sensgul M, Ozbel Y. Serological and Entomological Survey of Zoonotic Visceral Leishmaniasis in Denizli Province, Aegean Region, Turkey. New Microbiologica, 2009;32:93-100. 10. Bosilkovski M, Dimozva M, Stevanovic M, Cvetkovska VS, Duganovska M. Fever of unknown origin--diagnostic methods in a European developing country. Voinosanit Pregl 2016;73:553-8. 11. WOrld Health Organization. Available from: https://www.who.int/ leishmaniasis/resources/Turkey_CP_2014.pdf 12. Bekele T. Guideline for diagnosis, treatment and prevention of visceral leishmaniasis in Ethiopia. 2nd ed. 2013 13. Srivastava P, Dayama A, Mehrotra S, & Sundar S. Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 2011;105:1-6. 14. Moore EM, Lockwood DN. Treatment of Visceral Leishmaniasis. J Glob Infect Dis 2010;2:151-8.